ArticleNuclear medicine communications2026

The proportion, clinical predictors, and prognostic impact of hypometabolic estrogen receptor-positive primary breast cancer on baseline [ 18 F] fluorodeoxyglucose PET.

Melissa Lenaerts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.